CIK 0000025743 · Non-accelerated filer<br>Smaller reporting company
TherapeuticsMD, Inc.
Sign in to watch- Ticker
- TXMD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 870233535
- Phone
- 561-961-1900
- Business address
- 951 YAMATO ROAD, SUITE 220, BOCA RATON, FL, 33431
- Former names
- AMHN, Inc., CROFF ENTERPRISES INC, CROFF OIL CO
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-04-12 | Walker Marlan D Chief Executive Officer | Option exercise | +3,030 | 8,999 | ||
| 2023-04-12 | Walker Marlan D Chief Executive Officer | Option exercise | +1,010 | 10,009 | ||
| 2023-04-12 | Walker Marlan D Chief Executive Officer | Option exercise | +1,734 | 11,743 | ||
| 2023-04-12 | Walker Marlan D Chief Executive Officer | Option exercise | +1,734 | 13,477 | ||
| 2023-04-12 | Walker Marlan D Chief Executive Officer | Sale | −1,170 | $3.65 | $4K | 12,307 |
| 2023-04-12 | Walker Marlan D Chief Executive Officer | Option exercise · Performance Stock Units | −3,030 | 0 | ||
| 2023-04-12 | Walker Marlan D Chief Executive Officer | Option exercise · Restricted Stock Units | −1,010 | 0 | ||
| 2023-04-12 | Walker Marlan D Chief Executive Officer | Option exercise · Restricted Stock Units | −1,734 | 3,466 | ||
| 2023-04-12 | Walker Marlan D Chief Executive Officer | Option exercise · Performance Stock Units | −1,734 | 3,466 | ||
| 2023-04-12 | Donegan Michael C Prin. Fin. and Acctg. Officer | Option exercise | +50,000 | 61,853 | ||
| 2023-04-12 | Donegan Michael C Prin. Fin. and Acctg. Officer | Option exercise · Restricted Stock Units | −50,000 | 0 | ||
| 2023-02-21 | Walker Marlan D Chief Executive Officer | Grant or award · Restricted Stock Units | +70,000 | 70,000 | ||
| 2023-02-21 | Donegan Michael C Prin. Fin. and Acctg. Officer | Grant or award · Restricted Stock Units | +50,000 | 50,000 | ||
| 2023-01-27 | Donegan Michael C Prin. Fin. and Acctg. Officer | Sale | −49 | $5.09 | $249 | 11,853 |
| 2023-01-26 | Donegan Michael C Prin. Fin. and Acctg. Officer | Option exercise | +2,400 | 10,010 | ||
| 2023-01-26 | Donegan Michael C Prin. Fin. and Acctg. Officer | Option exercise | +2,400 | 12,410 | ||
| 2023-01-26 | Donegan Michael C Prin. Fin. and Acctg. Officer | Option exercise | +1,140 | 13,550 | ||
| 2023-01-26 | Donegan Michael C Prin. Fin. and Acctg. Officer | Sale | −1,648 | $5.08 | $8K | 11,902 |
| 2023-01-26 | Donegan Michael C Prin. Fin. and Acctg. Officer | Option exercise · Performance Stock Units | −2,400 | 0 | ||
| 2023-01-26 | Donegan Michael C Prin. Fin. and Acctg. Officer | Option exercise · Performance Stock Units | −2,400 | 0 |
Page 3 of 11 · 206 trades